Related Experiment Video

Updated: Feb 2, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K

Macropolycyte in Pediatrics

Anselm Chi-Wai Lee1

  • 1Children's Haematology and Cancer Centre, Mount Elizabeth Hospital, Singapore, Singapore.

Journal of Pediatric Hematology/Oncology
|November 27, 2018
PubMed

Insights

Macropolycytes, large tetraploid neutrophils, are linked to accelerated myelopoiesis. These cells, previously seen in adults, are now reported in children after G-CSF treatment and Kawasaki disease.

Area of Science:

  • Hematology
  • Cell Biology
  • Pediatric Medicine

Background:

  • Macropolycytes are large, tetraploid neutrophils.
  • Their formation is associated with accelerated myelopoiesis.
  • Previously documented in adults with pernicious anemia, sepsis, and post-chemotherapy.

Observation:

  • Two pediatric cases of macropolycyte presence are detailed.
  • Case 1: Macropolycytes observed after granulocyte colony-stimulating factor (G-CSF) treatment.
  • Case 2: Macropolycytes observed following Kawasaki disease.

Findings:

  • This study expands the known clinical contexts for macropolycytes.
  • It highlights their occurrence in pediatric patients under specific conditions.
  • Demonstrates G-CSF and Kawasaki disease as potential triggers for macropolycyte production in children.

Implications:

  • Suggests macropolycytes may serve as a biomarker in pediatric conditions.
  • Warrants further investigation into the mechanisms of macropolycyte formation in response to G-CSF and inflammatory diseases like Kawasaki disease.
  • Contributes to understanding neutrophil kinetics and pathology in pediatric hematology.

More Related Videos

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry03:37

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

Published on: June 6, 2025

468
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.4K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
298